Crestchem Limited has disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that its subsidiary, Oleo Biosciences Private Limited, has successfully completed the filing of Form INC-20A (Declaration for Commencement of Business) with the Registrar of Companies and has accordingly commenced its business operations. The disclosure was made on May 7, 2026, from Ahmedabad, signed by Company Secretary & Compliance Officer Nitin S. Shah. The subsidiary is now in the process of initiating activities related to the establishment of a pilot plant and product development machineries at Bangalore, Karnataka.

Subsidiary Formation and Shareholding Structure

Oleo Biosciences Private Limited was incorporated as a new entity under the Companies Act, 2013, with Crestchem Limited holding a 75% stake and a minority promoter holding the remaining 25%. The subsidiary was established with an initial authorized and paid-up capital of Rs.10,00,000/-, with Crestchem subscribing to 75,000 equity shares at Rs.10/- each, representing a total investment of Rs.7,50,000/-. The following table summarises the key shareholding and investment details:

Business Objectives and Regulatory Details

The subsidiary has been formed with the primary objective of establishing a pilot plant and machineries for the manufacture of oleo chemicals, which are speciality chemicals and related products, to cater to existing and potential customers in southern India. The disclosure provides the following details as required under the SEBI Circular dated July 13, 2023:

Management and Compliance

Mr. Dipak Narendraprasad Patel, Managing Director of Crestchem Limited, has been appointed as Director of Oleo Biosciences Private Limited to strategically oversee the subsidiary's affairs. Day-to-day operational and management responsibilities will be handled by local onsite management personnel stationed in Bangalore. The board had also authorised Mr. Patel to sign all related documents and perform necessary acts for the subsidiary's business operations. A rental agreement has been executed to acquire a shed for installing the pilot plant, machinery, laboratory, and product development equipment, and investment matters have been addressed under Sections 179 and 186 of the Companies Act, 2013, ensuring compliance with prescribed limits and applicable provisions.

Crestchem Limited has submitted mandatory regulatory disclosures to the Bombay Stock Exchange regarding promoter shareholdings as on March 31, 2026. The company filed these disclosures under Regulation 30(1), 30(2), and 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011.

Promoter Shareholding Details

The disclosure reveals that the promoter group, led by Mr. Dipak Patel and persons acting in concert, holds a significant stake in the company. The total promoter shareholding stands at 9,01,049 shares, representing 30.03% of the company's total share capital as on March 31, 2026.

Individual Promoter Holdings

The disclosure provides a detailed breakdown of individual shareholdings within the promoter group:

The filing indicates that Mr. Dipak Narendraprasad Patel holds the majority of the promoter stake with 8,86,443 shares (29.55%), while Sonali N Patel holds 14,600 shares (0.48%).

Regulatory Compliance

The company has fulfilled its regulatory obligations by submitting comprehensive disclosures under multiple SEBI regulations. The filings include:

• Disclosure under Regulation 30(1) and 30(2) for substantial shareholding
• Annual disclosure under Regulation 31(4) for the year ended March 31, 2026
• Confirmation of no encumbrance of shares during the financial year

Company Information

Crestchem Limited is listed on the Bombay Stock Exchange with BSE code 526269. The company's corporate office is located in Ahmedabad, Gujarat. Nitin S. Shah serves as the Company Secretary and Compliance Officer, who signed the regulatory filings on April 3, 2026.

The disclosure confirms that the promoter group maintained their shareholding position without any encumbrance of shares during the financial year ended March 31, 2026, demonstrating stable promoter commitment to the company.